Literature DB >> 2818258

Antineural autoantibodies in patients with paraneoplastic cerebellar degeneration.

T Tsukamoto1, H Yamamoto, Y Iwasaki, O Yoshie, H Terunuma, H Suzuki.   

Abstract

We studied serum autoantibodies from six patients with paraneoplastic cerebellar degeneration using rat brains. Immunohistochemically, serum samples from four of six patients with uterine or ovarian tumors showed a similar staining pattern, labeling Purkinje cells and various other neurons distributed throughout the brain and spinal cord. The immunoblot study showed that these serum samples recognized the common 52-kd band. Serum from a patient with duct carcinoma of the breast reacted with the 46-kd band with a similar but weaker immunohistochemical reactivity. Serum from another patient with small-cell carcinoma of the lung in whom paraneoplastic cerebellar degeneration and Eaton-Lambert myasthenic syndrome developed recognized the 40-kd and 38-kd bands with a different immunostaining pattern. Autoantibodies in patients with paraneoplastic cerebellar degeneration are directed to a variety of neuronal antigens that may differ from patient to patient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818258     DOI: 10.1001/archneur.1989.00520470093033

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.

Authors:  J E Greenlee; H R Brashear; K A Jaeckle; A Geleris; K Jordan
Journal:  West J Med       Date:  1992-02

3.  Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu).

Authors:  F Heidenreich; R Schober; U Brinck; H P Hartung
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

4.  Circulating autoantibodies against central nervous system (CNS) antigens in neurological diseases.

Authors:  B Giometto; F Bozza; F Faresin; C Peron; V Argentiero; P Gallo; B Tavolato
Journal:  Ital J Neurol Sci       Date:  1994-05

5.  A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues.

Authors:  J P Corradi; C Yang; J C Darnell; J Dalmau; R B Darnell
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

6.  Human autoantibodies against desmoplakins in paraneoplastic pemphigus.

Authors:  J R Oursler; R S Labib; L Ariss-Abdo; T Burke; E J O'Keefe; G J Anhalt
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

7.  Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells.

Authors:  H Tomimoto; J M Brengman; T Yanagihara
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Autoantibodies to neuronal glutamate receptors in patients with paraneoplastic neurodegenerative syndrome enhance receptor activation.

Authors:  L C Gahring; R E Twyman; J E Greenlee; S W Rogers
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

9.  Paraneoplastic cerebellar degeneration and limbic encephalitis in a patient with adenocarcinoma of the colon.

Authors:  T Tsukamoto; R Mochizuki; H Mochizuki; M Noguchi; H Kayama; M Hiwatashi; T Yamamoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

10.  The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer.

Authors:  G Cavaletti; G Bogliun; L Marzorati; M Marzola; M R Pittelli; G Tredici
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.